Humana AB (LTS:0RF7) Research & Development: kr0 Mil (TTM As of Mar. 2026)


LTS:0RF7 Humana AB LTS:0RF7
67 GF Score
Price kr48.13
GF Value kr36.46
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Humana AB Research & Development?

Humana AB LTS:0RF7 +3.44% 67 Research & Development is kr0 Mil as of Mar. 2026. GuruFocus rates LTS:0RF7 with a GF Score™ of 67/100 and a GF Value™ of kr36.46 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Humana AB's Research & Development for the three months ended in Mar. 2026 was kr0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was kr0 Mil.

Humana AB  (LTS:0RF7) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Humana AB Research & Development Related Terms

Humana AB Research & Development Historical Data

* Premium members only.

The historical data trend for Humana AB's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Humana AB Research & Development Chart

Humana AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Humana AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
LTS:0RF7
67GF Score
Humana AB LTS:0RF7
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Humana AB Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of kr0 Mil mean?
Humana AB (LTS:0RF7) has a Research & Development of kr0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Humana AB and its competitors.
Is Humana AB's Research & Development too high?
Humana AB's current Research & Development is kr0 Mil. Overall, Humana AB has a GF Score™ of 67/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Humana AB's Research & Development compare to HCA and THC?
Humana AB's Research & Development of kr0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Humana AB and its competitors. Humana AB's current Research & Development is kr0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Humana AB stock overvalued right now?
Based on GuruFocus' analysis, Humana AB (LTS:0RF7) is currently considered Significantly Overvalued. The stock's GF Value™ is kr36.46, compared to a current price of kr48.13 — trading 32% above its estimated fair value. The current Research & Development is kr0 Mil. Humana AB's overall GF Score™ is 67/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Humana AB (LTS:0RF7), the current Research & Development is kr0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Humana AB (LTS:0RF7) Overvalued in 2026?

Based on GuruFocus' analysis, Humana AB stock appears to be overvalued. The current stock price of kr48.13 is trading 32% above its estimated GF Value™ of kr36.46. GuruFocus considers Humana AB to be Significantly Overvalued.

Key valuation signals for LTS:0RF7:

  • Research & Development: kr0 Mil
  • GF Value™: kr36.46 vs. price of kr48.13 (32% above fair value)
  • GF Score™: 67/100 with 3 warning signs

No single metric tells the full story. See the LTS:0RF7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Humana AB Business Description

Other Exchanges HUM:SwedenHUMs:UK
Address Warfvinges vag 39, 7th Floor, Stockholm, SWE, SE-112 51
Humana AB is a provider of private care services in the Nordic region. The company offers services including individual and family care, personal assistance, elderly care and housing with special services. Geographically, the company operates in Sweden, Norway, Finland, Denmark, and others. It derives maximum revenue from Sweden.
67GF Score

Get the complete analysis for LTS:0RF7

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr48.13
Price
kr36.46
GF Value